Opening Keynote Presentation:
The Regulatory Outlook for Future Vaccine Adjuvants
Norman W. Baylor, Ph.D., President and CEO, Biologics Consulting Group, Inc.
Synthetic Biology for Developing Vaccines
Bolyn Hubby, Ph.D., Senior Director, Head, Vaccine and Phage R&D, Synthetic
Genomics Vaccines, Inc.
Putting Cancer in Check with Novel Immunomodulatory Strategies
Postow, M.D., Assistant Attending Physician, Melanoma and Immunotherapeutics
Service, Memorial Sloan-Kettering Cancer Center
Update from 2014 ASCO Meeting: Clinical Trials for Immunotherapy Combinations
M.D., Director, Melanoma Center, Angeles Clinic and Research Institute